Product Information

GLYCOPYRROLATE 0.2 MG/ML VIAL is a generic product labeled by American Regent, Inc., priced at $1.5794 per ML under NDC 00517460125. Its NADAC has been published 100 times since Dec 18, 2024.

FDA first approved this application on Jul 23, 1986. Its Orange Book therapeutic-equivalence code is AP.

GLYCOPYRROLATE 0.2 MG/ML VIAL

Glycopyrrolate
$1.5794per ML

Strength

.2 mg/mL

NDC

00517460125

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

INTRAMUSCULAR; INTRAVENOUS

Effective Date

10/21/2026

Active Ingredients

GLYCOPYRROLATE

Approval Type

Generic (ANDA)

FDA Application

ANDA089335

FDA Approved

7/23/1986

TE Code

AP

On Market Since

9/30/1990

Pharmacological Classes

Anticholinergic
Cholinergic Antagonists
Cholinergic Muscarinic Antagonist
Cholinergic Muscarinic Antagonists

Price Statistics

The NADAC for GLYCOPYRROLATE 0.2 MG/ML VIAL has been published 100 times since Dec 18, 2024, and over the history we have for it it has risen 13.0%. The table below summarizes its recorded NADAC range and movement.

Current price$1.5794 per ML
All-time high$1.5856 (Aug 13, 2025)
All-time low$1.2855 (May 20, 2026)
52-week high$1.5794
52-week low$1.2855
Median price$1.5059
Average price$1.4608
Largest weekly change-14.9% (Mar 18, 2026)
Weeks tracked100
Tracking sinceDec 18, 2024

Price History

1W

0.0%

1M

+4.3%

3M

+13.3%

6M

+22.5%

1Y

+4.3%

3Y

N/A

5Y

N/A

All

+13.0%

Generic Alternatives

The matcher finds 11 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 4% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of GLYCOPYRROLATE 0.2 MG/ML VIAL?

The current National Average Drug Acquisition Cost (NADAC) for GLYCOPYRROLATE 0.2 MG/ML VIAL, manufactured by American Regent, Inc., is $1.5794 per ML (NDC 00517460125), effective Nov 11, 2026.

How has the price of GLYCOPYRROLATE 0.2 MG/ML VIAL changed over time?

Over the history we have for it, the NADAC for GLYCOPYRROLATE 0.2 MG/ML VIAL has risen 13.0%. It has been tracked across 100 weekly CMS publications since Dec 18, 2024.

What are the highest and lowest recorded NADAC prices for GLYCOPYRROLATE 0.2 MG/ML VIAL?

Since Dec 18, 2024, the NADAC for GLYCOPYRROLATE 0.2 MG/ML VIAL has ranged from a low of $1.2855 (May 20, 2026) to a high of $1.5856 (Aug 13, 2025), with a median of $1.5059 per ML.

Are there cheaper alternatives to GLYCOPYRROLATE 0.2 MG/ML VIAL?

Yes. 11 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, GLYCOPYRROLATE 0.2 MG/ML VIAL, is $1.5137 per ML — about 4% below GLYCOPYRROLATE 0.2 MG/ML VIAL.

Who manufactures GLYCOPYRROLATE 0.2 MG/ML VIAL?

GLYCOPYRROLATE 0.2 MG/ML VIAL (NDC 00517460125) is labeled by American Regent, Inc., and CMS classifies it as a generic product.